ETFB (P38117) variants and mutations
ETFB (also known as P38117) is a human protein-coding gene encoding an electron transfer flavoprotein subunit beta protein. It accepts electrons from multiple mitochondrial flavoprotein dehydrogenases and transfers them toward the respiratory chain through ETF dehydrogenase. Biallelic loss-of-function variants cause multiple acyl-CoA dehydrogenase deficiency, disrupting fatty-acid and amino-acid oxidation. This analysis covers 599 ETFB variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes multiple acyl-CoA dehydrogenase deficiency, Elevated circulating glutaric acid concentration, and glutaric aciduria. Example ETFB variants include M1T, A2E, and E3*.
Variant analysis overview
- Gene: ETFB
- Protein: P38117
- UniProt accession: P38117
- Organism: Homo sapiens
- Variants analyzed: 599
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 347 unspecified-consequence records; 1 stop lost; 1 stop retained variant; 22 frameshift variants; 111 synonymous variants; 101 missense variants; 4 in-frame deletions; 5 stop-gained variants; 1 in-frame insertions; 2 splice-region variants; 4 substitution
- Prediction scores: 495 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: multiple acyl-CoA dehydrogenase deficiency, Elevated circulating glutaric acid concentration, glutaric aciduria, multiple acyl-CoA dehydrogenase deficiency, mild type, multiple acyl-CoA dehydrogenase deficiency, severe neonatal type, hereditary disease, chronic kidney disease, glutaric acidemia IIc, acute myeloid leukemia, retinitis pigmentosa, Cone rod dystrophy, Leber congenital amaurosis.
Protein structure and variant hotspots
- Protein features: 11 binding sites; 12 post-translational modification sites.
- PTM context: 16 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ETFB variants
Examples include M1T, A2E, E3*, E3Q, L4P, R5C, R5L, R5S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs746888203, ClinGen CA9610965, ClinVar RCV002765576, MetaLR 0.66, MetaSVM 0.44, Conflicting interpretations, Multiple acyl-CoA dehydrogenase deficiency
- A2E (p.Ala2Glu), TOPMed rs1247804968, REVEL 0.52, CADD 25.50
- E3* (p.Glu3Ter), ESP rs370961463, ExAC rs370961463, TOPMed rs370961463, gnomAD rs370961463, CADD 41.00
- E3Q (p.Glu3Gln), ESP rs370961463, ExAC rs370961463, TOPMed rs370961463, gnomAD rs370961463, REVEL 0.24, CADD 22.70
- L4P (p.Leu4Pro), Ensembl rs2123621082, REVEL 0.72, CADD 32.00
- R5C (p.Arg5Cys), TOPMed rs1422832903, gnomAD rs1422832903, REVEL 0.64, CADD 33.00
- R5L (p.Arg5Leu), rs949269058, ClinGen CA309746130, ClinVar RCV002751596, ClinVar RCV005333337, REVEL 0.67, CADD 29.10, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency; Inborn genetic diseases
- R5S (p.Arg5Ser), cosmic curated COSV52467
- V6A (p.Val6Ala), TOPMed rs1227484897, gnomAD rs1227484897, REVEL 0.24, CADD 23.00
- V6G (p.Val6Gly), cosmic curated COSV52467
- V6L (p.Val6Leu), TOPMed rs1306468501, REVEL 0.44, CADD 22.90
- L7F (p.Leu7Phe), TOPMed rs1459444364, gnomAD rs1459444364, REVEL 0.71, CADD 28.00, Uncertain significance, not provided
- V8I (p.Val8Ile), rs531136177, ClinGen CA9610959, ClinVar RCV001932399, ClinVar RCV002550998, REVEL 0.62, CADD 27.00, Uncertain significance, not provided; Multiple acyl-CoA dehydrogenase deficiency; Inborn genetic disease
- V8L (p.Val8Leu), rs531136177, 1000Genomes rs531136177, ExAC rs531136177, TOPMed rs531136177, REVEL 0.76, CADD 28.20, Uncertain significance, Inborn genetic diseases
- A9D (p.Ala9Asp), cosmic curated COSV52467
- A9S (p.Ala9Ser), NCI-TCGA Cosmic COSV9939, cosmic curated COSV99390, Variant assessed as somatic; moderate impact.
- A9T (p.Ala9Thr), gnomAD rs1442687835, REVEL 0.50, CADD 23.50
- A9V (p.Ala9Val), ExAC rs764471064, gnomAD rs764471064, REVEL 0.48, CADD 24.20
- V10L (p.Val10Leu), 1000Genomes rs563834980, REVEL 0.69, CADD 24.80
- K11* (p.Lys11Ter), Ensembl rs1986365106
- K11E (p.Lys11Glu), Ensembl rs1986365106
- K11R (p.Lys11Arg), cosmic curated COSV52467, REVEL 0.85, CADD 32.00
- R12K (p.Arg12Lys), cosmic curated COSV52467, gnomAD rs1480479389, REVEL 0.76, CADD 28.90
- V13G (p.Val13Gly), Ensembl rs1599849584
- V13L (p.Val13Leu), Ensembl rs2123620977
- I14L (p.Ile14Leu), rs148261223, ClinGen CA9610957, ClinVar RCV001944138, ClinVar RCV002561431, REVEL 0.63, CADD 32.00, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency; Inborn genetic diseases; not provide
- I14T (p.Ile14Thr), rs1568471932, cosmic curated COSV52468, NCI-TCGA Cosmic COSV5246, REVEL 0.76, CADD 32.00, Variant assessed as somatic; moderate impact.
- D15A (p.Asp15Ala), TOPMed rs981006954, gnomAD rs981006954, REVEL 0.85, CADD 32.00
- D15G (p.Asp15Gly), TOPMed rs981006954, gnomAD rs981006954, REVEL 0.87, CADD 32.00
- Y16* (p.Tyr16Ter), cosmic curated COSV52467
- Y16H (p.Tyr16His), Ensembl rs1986364552, REVEL 0.48, CADD 32.00
- A17G (p.Ala17Gly), gnomAD rs1434234790, REVEL 0.47, CADD 25.40
- A17S (p.Ala17Ser), rs1333299560, ClinGen CA407087160, ClinVar RCV003078435, gnomAD rs1333299560, REVEL 0.47, CADD 25.40, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- V18A (p.Val18Ala), TOPMed rs1428028565, gnomAD rs1428028565, REVEL 0.50, CADD 24.80, Uncertain significance, Inborn genetic diseases
- V18G (p.Val18Gly), rs1428028565, ClinGen CA407087129, ClinVar RCV003624168, TOPMed rs1428028565, REVEL 0.72, CADD 29.50, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- V18L (p.Val18Leu), rs1986364163, ClinGen CA407087135, ClinVar RCV002819796, TOPMed rs1986364163, AlphaMissense 0.88, MetaLR 0.52, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- K19R (p.Lys19Arg), ExAC rs767751467, gnomAD rs767751467, REVEL 0.55, CADD 35.00
- I20N (p.Ile20Asn), ExAC rs746284138, gnomAD rs746284138, REVEL 0.75, CADD 25.40
- R21* (p.Arg21Ter), rs374288379, ClinGen CA9610876, cosmic curated COSV58535, ClinVar RCV003476354, CADD 36.00, PolyPhen-2 0.02, Pathogenic
- R21G (p.Arg21Gly), ESP rs374288379, ExAC rs374288379, TOPMed rs374288379, gnomAD rs374288379, REVEL 0.86, CADD 24.40, Pathogenic
- R21L (p.Arg21Leu), cosmic curated COSV58536, ESP rs369216610, ExAC rs369216610, TOPMed rs369216610, REVEL 0.82, CADD 25.90, Uncertain significance
- R21P (p.Arg21Pro), rs369216610, ClinGen CA9610874, ClinVar RCV004383103, ESP rs369216610, REVEL 0.85, CADD 25.90, Uncertain significance, Inborn genetic diseases
- R21Q (p.Arg21Gln), rs369216610, ClinGen CA309738061, ClinVar RCV001974033, ClinVar RCV005834164, REVEL 0.69, CADD 25.70, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency; Inborn genetic diseases
- V22L (p.Val22Leu), ExAC rs754545072, TOPMed rs754545072, gnomAD rs754545072, REVEL 0.62, CADD 23.50
- K23M (p.Lys23Met), Ensembl rs1986017229
- K23N (p.Lys23Asn), TOPMed rs371201213, gnomAD rs371201213, REVEL 0.36, CADD 22.70, Likely benign
- P24A (p.Pro24Ala), TOPMed rs1241346242, gnomAD rs1241346242, REVEL 0.40, CADD 23.00
- P24T (p.Pro24Thr), TOPMed rs1241346242, gnomAD rs1241346242, REVEL 0.53, CADD 23.60
- D25G (p.Asp25Gly), NCI-TCGA Cosmic COSV5853, cosmic curated COSV58535, Variant assessed as somatic; moderate impact.
- R26S (p.Arg26Ser), rs564020088, ClinGen CA9610870, ClinVar RCV002636931, 1000Genomes rs564020088, REVEL 0.13, CADD 14.30, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- R26W (p.Arg26Trp), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10049, Variant assessed as somatic; moderate impact.
- T27N (p.Thr27Asn), cosmic curated COSV10049
- G28R (p.Gly28Arg), rs750230877, ClinGen CA407083495, ClinVar RCV002598342, ClinVar RCV006372916, REVEL 0.54, CADD 23.70, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- G28S (p.Gly28Ser), rs750230877, ClinGen CA9610868, ClinVar RCV001925930, ClinVar RCV002556356, REVEL 0.48, CADD 23.60, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- V29M (p.Val29Met), ExAC rs765099692, gnomAD rs765099692, REVEL 0.69, CADD 24.90
- T31M (p.Thr31Met), rs371751519, ClinGen CA9610866, cosmic curated COSV58536, ClinVar RCV001924272, REVEL 0.65, CADD 23.20, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- D32G (p.Asp32Gly), gnomAD rs1421751089
- G33D (p.Gly33Asp), rs368139326, ClinGen CA407083436, ClinVar RCV002755179, AlphaMissense 0.74, MetaLR 0.83, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- G33V (p.Gly33Val), ESP rs368139326, ExAC rs368139326, TOPMed rs368139326, gnomAD rs368139326, REVEL 0.87, AlphaMissense 0.74
- H36Y (p.His36Tyr), TOPMed rs1986015863
- M38L (p.Met38Leu), ExAC rs760800809, TOPMed rs760800809, gnomAD rs760800809, REVEL 0.52, CADD 22.70
- M38T (p.Met38Thr), rs775541180, ClinGen CA9610862, ClinVar RCV001362604, ExAC rs775541180, REVEL 0.83, CADD 25.70, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- M38V (p.Met38Val), ExAC rs760800809, TOPMed rs760800809, gnomAD rs760800809, REVEL 0.68, CADD 23.30
- N39I (p.Asn39Ile), TOPMed rs1473834913
- P40T (p.Pro40Thr), rs772322071, ClinGen CA9610861, ClinVar RCV001244954, ClinVar RCV003166537, REVEL 0.88, CADD 27.90, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency; not provide
- P40L (p.Pro40Leu), rs79338777, Benign
- F41L (p.Phe41Leu), cosmic curated COSV58537, TOPMed rs1261822150, gnomAD rs1261822150, REVEL 0.81, CADD 32.00
- F41S (p.Phe41Ser), rs746082442, ClinGen CA9610860, ClinVar RCV000538071, ExAC rs746082442, REVEL 0.93, CADD 32.00, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- C42R (p.Cys42Arg), rs774387920, ClinGen CA9610859, ClinVar RCV003476359, ExAC rs774387920, REVEL 0.82, CADD 25.10, Pathogenic/Likely pathogenic, Multiple acyl-CoA dehydrogenase deficiency
- E43D (p.Glu43Asp), TOPMed rs1986014874, gnomAD rs1986014874, REVEL 0.67, CADD 24.10
- I44M (p.Ile44Met), ESP rs374935848, ExAC rs374935848, TOPMed rs374935848, gnomAD rs374935848, REVEL 0.56, CADD 22.10, Uncertain significance, Inborn genetic diseases
- A45E (p.Ala45Glu), ExAC rs770414295, TOPMed rs770414295, gnomAD rs770414295, REVEL 0.97, CADD 28.10, Uncertain significance, Inborn genetic diseases
- A45T (p.Ala45Thr), rs151108898, ClinGen CA9610856, ClinVar RCV002017443, ESP rs151108898, REVEL 0.87, CADD 26.70, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- A45V (p.Ala45Val), rs770414295, ClinGen CA9610855, NCI-TCGA Cosmic COSV5853, cosmic curated COSV58537, REVEL 0.94, CADD 28.60, Uncertain significance, not specified; Multiple acyl-CoA dehydrogenase deficiency
- V46L (p.Val46Leu), TOPMed rs1986014276, REVEL 0.38, CADD 17.60
- E47K (p.Glu47Lys), gnomAD rs1340010576, REVEL 0.93, CADD 28.70
- E47Q (p.Glu47Gln), gnomAD rs1340010576, REVEL 0.86, CADD 27.00
- E48K (p.Glu48Lys), rs750117869, ClinGen CA9610851, ClinVar RCV001996102, ExAC rs750117869, REVEL 0.80, CADD 29.10, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- A49S (p.Ala49Ser), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10049, Variant assessed as somatic; moderate impact.
- A49T (p.Ala49Thr), Ensembl rs1986013640
- R51G (p.Arg51Gly), rs1308673942, ClinGen CA407083215, ClinVar RCV003035340, AlphaMissense 0.73, MetaLR 0.76, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- R51Q (p.Arg51Gln), rs1402136329, ClinGen CA407083211, NCI-TCGA Cosmic COSV1004, cosmic curated COSV10049, REVEL 0.53, CADD 28.60, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- R51W (p.Arg51Trp), NCI-TCGA Cosmic COSV5853, cosmic curated COSV58536, TOPMed rs1308673942, gnomAD rs1308673942, REVEL 0.64, AlphaMissense 0.73, Likely benign
- K53N (p.Lys53Asn), ESP rs368212620, ExAC rs368212620, TOPMed rs368212620, gnomAD rs368212620, REVEL 0.76, CADD 26.80
- E54D (p.Glu54Asp), cosmic curated COSV10517
- E54K (p.Glu54Lys), rs796051954, ClinGen CA312502, ClinVar RCV000185878, Ensembl rs796051954, AlphaMissense 0.95, MetaLR 0.83, Likely pathogenic, not provided
- K55* (p.Lys55Ter), rs2514155556, ClinGen CA407083166, ClinVar RCV003476352, CADD 41.00, Likely pathogenic
- K55R (p.Lys55Arg), TOPMed rs1465301474, gnomAD rs1465301474, REVEL 0.50, CADD 28.10, Uncertain significance, not provided
- K56N (p.Lys56Asn), cosmic curated COSV58535, ExAC rs764083482, gnomAD rs764083482, REVEL 0.34, CADD 20.40
- K56Q (p.Lys56Gln), rs757088247, ClinGen CA9610849, ClinVar RCV003105205, ClinVar RCV004244558, REVEL 0.45, CADD 23.30, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- L57P (p.Leu57Pro), ExAC rs752825481, TOPMed rs752825481, gnomAD rs752825481, REVEL 0.60, CADD 29.40
- E60* (p.Glu60Ter), rs1193726585, ClinGen CA407083102, ClinVar RCV003857880, TOPMed rs1193726585, CADD 44.00, Pathogenic
- V61G (p.Val61Gly), Ensembl rs1599843101, REVEL 0.85, CADD 29.70
- V61I (p.Val61Ile), TOPMed rs1986011889
- I62L (p.Ile62Leu), ExAC rs199705168, TOPMed rs199705168, gnomAD rs199705168, REVEL 0.25, CADD 23.70, Uncertain significance
- I62M (p.Ile62Met), rs374583902, ClinGen CA407083069, ClinVar RCV003002331, REVEL 0.60, CADD 18.20, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- I62V (p.Ile62Val), rs199705168, ClinGen CA9610840, ClinVar RCV001952981, ClinVar RCV002562826, REVEL 0.18, CADD 19.10, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- A63P (p.Ala63Pro), ESP rs142966954, ExAC rs142966954, TOPMed rs142966954, gnomAD rs142966954, REVEL 0.88, CADD 27.90
- A63T (p.Ala63Thr), cosmic curated COSV10439, ESP rs142966954, ExAC rs142966954, TOPMed rs142966954, REVEL 0.68, CADD 27.10
- V64I (p.Val64Ile), rs989233154, ClinGen CA309737889, ClinVar RCV003067514, ClinVar RCV004978541, REVEL 0.35, CADD 22.10, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- C66R (p.Cys66Arg), Ensembl rs1959329631
- G67R (p.Gly67Arg), Ensembl rs2123590695, REVEL 0.93, CADD 29.70
- P68A (p.Pro68Ala), ExAC rs770467292, TOPMed rs770467292, gnomAD rs770467292, CADD 16.10
- P68H (p.Pro68His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P68S (p.Pro68Ser), ExAC rs770467292, TOPMed rs770467292, gnomAD rs770467292, REVEL 0.71, CADD 26.00
- A69T (p.Ala69Thr), gnomAD rs1312209145, REVEL 0.17, CADD 7.80
- A69V (p.Ala69Val), gnomAD rs1396815248, REVEL 0.26, CADD 20.20
- C71G (p.Cys71Gly), TOPMed rs1986010377, REVEL 0.60, CADD 29.10
- C71Y (p.Cys71Tyr), cosmic curated COSV58537
- T74K (p.Thr74Lys), TOPMed rs1286614299, REVEL 0.88, CADD 25.60
- T74M (p.Thr74Met), cosmic curated COSV10963, TOPMed rs1286614299, REVEL 0.69, CADD 25.60
- T74T (p.Thr74Thr), rs548071177, gnomAD 19-51353285-C-T, CADD 13.80
- I75I (p.Ile75Ile), gnomAD 19-51353282-A-G, CADD 13.10
- R76C (p.Arg76Cys), cosmic curated COSV58535, ExAC rs777287614, TOPMed rs777287614, gnomAD rs777287614, REVEL 0.92, CADD 27.90
- R76H (p.Arg76His), rs148567433, ClinGen CA312504, cosmic curated COSV58537, ClinVar RCV000185879, REVEL 0.87, CADD 25.80, Uncertain significance, Inborn genetic diseases; not provided; Multiple acyl-CoA dehydrogenase deficienc
- T77I (p.Thr77Ile), TOPMed rs1299213601, gnomAD rs1299213601, REVEL 0.81, CADD 25.10
- T77N (p.Thr77Asn), TOPMed rs1299213601, gnomAD rs1299213601, REVEL 0.59, CADD 24.20
- T77T (p.Thr77Thr), rs147509776, gnomAD 19-51353276-G-A, CADD 0.07
- T77A (p.Thr77Ala), gnomAD 19-51353278-T-C, REVEL 0.71, CADD 24.40
- T77S (p.Thr77Ser), gnomAD 19-51353278-T-A, REVEL 0.69, CADD 23.90
- A78S (p.Ala78Ser), 1000Genomes rs548046212, ExAC rs548046212, TOPMed rs548046212, gnomAD rs548046212, REVEL 0.77, CADD 24.50, Likely pathogenic
- A78T (p.Ala78Thr), rs548046212, ClinGen CA312506, NCI-TCGA Cosmic COSV5853, cosmic curated COSV58537, REVEL 0.79, CADD 25.30, Uncertain significance, not specified; not provided; Multiple acyl-CoA dehydrogenase deficiency
- A78A (p.Ala78Ala), gnomAD 19-51353273-G-C, CADD 4.63
- A78D (p.Ala78Asp), gnomAD 19-51353274-G-T, REVEL 0.92, CADD 26.10
- L79P (p.Leu79Pro), rs770665020, ClinGen CA9610814, ClinVar RCV000996997, ExAC rs770665020, REVEL 0.96, AlphaMissense 0.91, Uncertain significance, not provided
- L79Q (p.Leu79Gln), rs770665020, ClinGen CA312508, ClinVar RCV000185881, ExAC rs770665020, AlphaMissense 0.91, MetaLR 0.90, Likely pathogenic, not provided
- L79L (p.Leu79Leu), rs1985974530, gnomAD 19-51353270-C-G, CADD 14.10
- A80T (p.Ala80Thr), rs2514153377, ClinGen CA407082739, ClinVar RCV004383102, Uncertain significance, Inborn genetic diseases
- M81V (p.Met81Val), rs748963409, ClinGen CA9610813, cosmic curated COSV58537, ClinVar RCV001806469, REVEL 0.82, CADD 24.40, Uncertain significance, not provided
- G82C (p.Gly82Cys), gnomAD rs1237704229, REVEL 0.97, CADD 27.10
- G82S (p.Gly82Ser), gnomAD 19-51353263-C-T, REVEL 0.97, CADD 26.20
- A83E (p.Ala83Glu), Ensembl rs923365001, REVEL 0.95, CADD 28.20
- A83T (p.Ala83Thr), rs1352787179, ClinGen CA407082700, ClinVar RCV002011512, ClinVar RCV004616959, REVEL 0.87, CADD 26.90, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- A83V (p.Ala83Val), gnomAD 19-51353259-G-A, REVEL 0.85, CADD 25.20
- D84H (p.Asp84His), cosmic curated COSV10517
- D84N (p.Asp84Asn), NCI-TCGA Cosmic COSV5853, cosmic curated COSV58535, Variant assessed as somatic; moderate impact.
- D84Y (p.Asp84Tyr), NCI-TCGA Cosmic COSV5853, cosmic curated COSV58535, Variant assessed as somatic; moderate impact.
- R85* (p.Arg85Ter), rs187424345, ClinGen CA9610811, ClinVar RCV001244975, 1000Genomes rs187424345, CADD 41.00, Pathogenic
- R85L (p.Arg85Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R85P (p.Arg85Pro), rs747881617, ClinGen CA407082672, ClinVar RCV003480339, AlphaMissense 0.24, MetaLR 0.77, Uncertain significance, not provided
- R85Q (p.Arg85Gln), rs747881617, ClinGen CA9610810, ClinVar RCV003051206, ClinVar RCV003076432, REVEL 0.82, AlphaMissense 0.24, Uncertain significance, Inborn genetic diseases; Multiple acyl-CoA dehydrogenase deficiency
- R85R (p.Arg85Arg), rs187424345, gnomAD 19-51353254-G-T, CADD 18.60
- G86A (p.Gly86Ala), rs143568332, ClinGen CA312510, ClinVar RCV001985428, ESP rs143568332, REVEL 0.60, AlphaMissense 0.37, Likely benign, Multiple acyl-CoA dehydrogenase deficiency
- G86D (p.Gly86Asp), cosmic curated COSV58536
- G86V (p.Gly86Val), rs143568332, ClinGen CA407082663, ClinVar RCV003003194, AlphaMissense 0.37, MetaLR 0.34, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- G86G (p.Gly86Gly), gnomAD 19-51353249-A-T, CADD 15.50
- G86S (p.Gly86Ser), gnomAD 19-51353251-C-T, REVEL 0.84, CADD 25.80
- I87V (p.Ile87Val), rs2123587270, ClinGen CA407082658, ClinVar RCV001871140, Ensembl rs2123587270, AlphaMissense 0.16, MetaLR 0.39, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency
- H88H (p.His88His), rs562266125, gnomAD 19-51353243-G-A, CADD 11.80
- H88Q (p.His88Gln), gnomAD 19-51353243-G-C, REVEL 0.68, CADD 19.50
- V89M (p.Val89Met), rs751703448, NCI-TCGA Cosmic COSV5853, cosmic curated COSV58536, ExAC rs751703448, REVEL 0.84, CADD 25.20, Variant assessed as somatic; moderate impact.
- V89V (p.Val89Val), rs984710058, gnomAD 19-51353240-C-T, CADD 16.00
- E90G (p.Glu90Gly), cosmic curated COSV10963
- E90Q (p.Glu90Gln), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10049, Variant assessed as somatic; moderate impact.
- E90E (p.Glu90Glu), rs1367066320, gnomAD 19-51353237-C-T, CADD 15.80
- V91G (p.Val91Gly), Ensembl rs1599842088, REVEL 0.80, CADD 26.10
- V91L (p.Val91Leu), TOPMed rs1985973375, REVEL 0.38, CADD 21.90
- V91V (p.Val91Val), rs766349894, gnomAD 19-51353234-C-T, CADD 5.81
- P92H (p.Pro92His), ExAC rs750675545, gnomAD rs750675545, REVEL 0.32, CADD 23.80
- P92L (p.Pro92Leu), ExAC rs750675545, gnomAD rs750675545
- P92S (p.Pro92Ser), rs758509148, ClinGen CA9610806, ClinVar RCV001332069, ClinVar RCV004035727, REVEL 0.12, CADD 12.60, Conflicting interpretations, not specified; Multiple acyl-CoA dehydrogenase deficiency; Glutaric acidemia IIc
- P92P (p.Pro92Pro), gnomAD 19-51353231-G-T, CADD 0.17
- P93L (p.Pro93Leu), rs139519507, ClinGen CA312492, ClinVar RCV000415826, ClinVar RCV000814061, REVEL 0.13, CADD 17.00, Conflicting interpretations, Inborn genetic diseases; not provided; Multiple acyl-CoA dehydrogenase deficienc
- P93T (p.Pro93Thr), cosmic curated COSV10049, CADD 13.20
- P93Q (p.Pro93Gln), gnomAD 19-51353228-TG-T, CADD 24.20
- P93S (p.Pro93Ser), gnomAD 19-51353230-G-A, REVEL 0.15, CADD 12.20
- A94S (p.Ala94Ser), cosmic curated COSV58536
- A94A (p.Ala94Ala), rs529873909, gnomAD 19-51353225-T-C, CADD 3.65
- A94E (p.Ala94Glu), gnomAD 19-51353226-G-T, REVEL 0.23, CADD 15.40
- E95D (p.Glu95Asp), ExAC rs777130490, TOPMed rs777130490, gnomAD rs777130490, REVEL 0.25, CADD 14.60, Likely benign
- E95K (p.Glu95Lys), Ensembl rs1568467589
- E95E (p.Glu95Glu), rs777130490, gnomAD 19-51353222-T-C, CADD 13.70
- E95A (p.Glu95Ala), gnomAD 19-51353223-T-G, REVEL 0.30, CADD 23.40
- A96G (p.Ala96Gly), TOPMed rs972043546, gnomAD rs972043546, REVEL 0.21, CADD 20.20
- R98C (p.Arg98Cys), rs147353781, ClinGen CA312494, cosmic curated COSV58535, ClinVar RCV000185874, REVEL 0.26, CADD 23.20, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- R98H (p.Arg98His), rs761063406, ClinGen CA9610802, cosmic curated COSV10809, ClinVar RCV001979000, REVEL 0.15, CADD 9.93, Uncertain significance, Multiple acyl-CoA dehydrogenase deficiency; Inborn genetic diseases
- L99L (p.Leu99Leu), rs776017865, gnomAD 19-51353210-C-T, CADD 16.70
- L99W (p.Leu99Trp), gnomAD 19-51353211-A-C, REVEL 0.82, CADD 27.50
- G100A (p.Gly100Ala), cosmic curated COSV10589
- P101H (p.Pro101His), gnomAD rs1249159210
Public ETFB analysis runs
- ETFB analysis run — ETFB (599 variants) — completed 2026-08-20